RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Biomedical Advanced Research and Development Authority (BARDA), under the Department of Health and Human Services, has issued a Request for Project Proposals (RPP) titled "Rapid Antigen Production for Immunoassay Diagnostics (RAPID)" through the Rapid Response Partnership Vehicle (RRPV) Consortium. This initiative seeks advanced research and development for rapid antibody and protein-based molecular recognition reagent generation platforms. Proposals are due May 13, 2026.
Scope of Work
BARDA aims to support the development of flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats. The primary objective is to significantly compress development timelines, ideally achieving assay-ready reagents within weeks from pathogen sequence identification. This effort focuses on timely production of immunoassay-ready reagents for diagnostic use.
Contract & Timeline
- Type: Request for Project Proposals (RPP) via RRPV Consortium (Special Notice)
- Agency: BARDA, HHS
- Set-Aside: None specified
- Proposer's Conference & Teaming Connect: Virtual, Monday, April 27, 2026, 11am-12pm EST
- Proposal Due: May 13, 2026, 5:00 PM EST
- Published: April 15, 2026
Additional Notes
The full RPP, registration details for the Proposer's Conference, and information on joining the RRPV Consortium are available on the RRPV website: www.rrpv.org. Interested offerors are encouraged to review the full RPP for complete submission requirements and evaluation criteria.